Literature DB >> 22120515

Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population.

Ying-Xue Wang1, Lei Zhao, Xiu-Yun Wang, Chang-Mei Liu, Su-Guo Yu.   

Abstract

Dysregulation of apoptosis plays a key role in carcinogenesis. This study was designed to investigate the association of apoptosis-related gene Caspase 8, Caspase 9 and Bcl-2 polymorphisms with papillary thyroid carcinoma (PTC) susceptibility. We undertook a case-control study of 118 patients and 213 controls to investigate the association between Caspase 8 (-652 6 N ins/del), Caspase 9 (-1263 A>G) and Bcl-2 (-938 C>A) polymorphisms and PTC susceptibility by polymerase chain reaction restriction-fragment length polymorphism and DNA sequencing methods. We further analyzed the distribution of genotype frequency, as well as the association of genotype with clinicopathological characteristics. Overall, no statistically significant association was observed in Caspase 8 (-652 6 N ins/del). Nevertheless, Caspase 9 -1263 GG genotype was at increased risk of PTC (P=0.045; odds ratio (OR)=1.12). Furthermore, GG genotype thyroid cancers were significantly more common in older patients than AA or AG genotypes PTC and in cases of advanced pathological stages. However, Bcl-2 -938 AA genotype demonstrated a protective effect in PTCs (P=0.004; OR=0.35). Polymorphism in Caspase 9 (-1263 A>G) was observed to be associated with susceptibility of PTC. However, Bcl-2 (-938 C>A) polymorphism indicated to play a protective role in susceptibility to PTC. Nevertheless, further investigation with a larger sample size is needed to support our results.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22120515     DOI: 10.1007/s12032-011-0121-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  40 in total

1.  BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism.

Authors:  Aneela Majid; Olga Tsoulakis; Renata Walewska; Stefan Gesk; Reiner Siebert; D Ben J Kennedy; Martin J S Dyer
Journal:  Blood       Date:  2007-10-24       Impact factor: 22.113

2.  A promoter polymorphism in the CASP8 gene is not associated with cancer risk.

Authors:  Christopher A Haiman; Rachel R Garcia; Laurence N Kolonel; Brian E Henderson; Anna H Wu; Loïc Le Marchand
Journal:  Nat Genet       Date:  2008-03       Impact factor: 38.330

Review 3.  Apoptosis in cancer: cause and cure.

Authors:  S H Kaufmann; G J Gores
Journal:  Bioessays       Date:  2000-11       Impact factor: 4.345

Review 4.  Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation.

Authors:  Dean A Fennell
Journal:  Clin Cancer Res       Date:  2005-03-15       Impact factor: 12.531

Review 5.  Apoptosome dysfunction in human cancer.

Authors:  K M Hajra; J R Liu
Journal:  Apoptosis       Date:  2004-11       Impact factor: 4.677

6.  Is ionizing radiation responsible for the increasing incidence of thyroid cancer?

Authors:  Yuri E Nikiforov
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

7.  The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.

Authors:  Hiroshi Hirata; Yuji Hinoda; Koichi Nakajima; Nobuyuki Kikuno; Yutaka Suehiro; Z Laura Tabatabai; Nobuhisa Ishii; Rajvir Dahiya
Journal:  J Urol       Date:  2009-06-18       Impact factor: 7.450

8.  The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia.

Authors:  M A Kaderi; M Norberg; F Murray; M Merup; C Sundström; G Roos; A Aleskog; K Karlsson; T Axelsson; G Tobin; R Rosenquist
Journal:  Leukemia       Date:  2007-11-29       Impact factor: 11.528

9.  Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.

Authors:  Ruchika Gangwar; Anil Mandhani; Rama Devi Mittal
Journal:  Ann Surg Oncol       Date:  2009-05-02       Impact factor: 5.344

10.  BCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibility.

Authors:  Ning Zhang; Xiaoyan Li; Kai Tao; Liyu Jiang; Tingting Ma; Shi Yan; Cunzhong Yuan; Meena S Moran; Faming Liang; Bruce G Haffty; Qifeng Yang
Journal:  BMC Med Genet       Date:  2011-04-01       Impact factor: 2.103

View more
  9 in total

1.  Identification of key genes of papillary thyroid cancer using integrated bioinformatics analysis.

Authors:  W Liang; F Sun
Journal:  J Endocrinol Invest       Date:  2018-03-08       Impact factor: 4.256

2.  Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis.

Authors:  Saman Sargazi; Armin Zahedi Abghari; Hosna Sarani; Roghayeh Sheervalilou; Shekoufeh Mirinejad; Ramin Saravani; Ebrahim Eskandari
Journal:  Appl Biochem Biotechnol       Date:  2021-08-31       Impact factor: 2.926

3.  Association of caspase9 promoter polymorphisms with the susceptibility of AML in south Indian subjects.

Authors:  Anuradha Cingeetham; Sugunakar Vuree; Nageswara Rao Dunna; Manjula Gorre; Santhoshi Rani Nanchari; Prajitha Mohandas Edathara; Phannibhusan Mekkaw; Sandhya Annamaneni; Raghunadha Rao Digumarthi; Sudha Sinha; Vishnupriya Satti
Journal:  Tumour Biol       Date:  2014-05-31

4.  A meta-analysis of caspase 9 polymorphisms in promoter and exon sequence on cancer susceptibility.

Authors:  Wei Xu; Shengqiang Jiang; Yuanyuan Xu; Bo Chen; Yan Li; Feng Zong; Weihong Zhao; Jianqing Wu
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

5.  CASP8 -652 6N insertion/deletion polymorphism and overall cancer risk: evidence from 49 studies.

Authors:  Jiarong Cai; Qingjian Ye; Suling Luo; Ze Zhuang; Kui He; Zhen-Jian Zhuo; Xiaochun Wan; Juan Cheng
Journal:  Oncotarget       Date:  2017-05-25

6.  Genetic polymorphisms of Bcl-2 promoter in cancer susceptibility and prognosis: a meta-analysis.

Authors:  Zhongqiang Yao; Binhui Yang; Zhongqiu Liu; Wei Li; Qihua He; Xingchun Peng
Journal:  Oncotarget       Date:  2017-04-11

7.  Role of Bcl-2 -938 C>A polymorphism in susceptibility and prognosis of cancer: a meta-analysis.

Authors:  Xiao Zhang; Wenhao Weng; Wen Xu; Yulan Wang; Wenjun Yu; Xun Tang; Lifang Ma; Qiuhui Pan; Jiayi Wang; Fenyong Sun
Journal:  Sci Rep       Date:  2014-11-28       Impact factor: 4.379

8.  Role of CASP7 polymorphisms in noise-induced hearing loss risk in Han Chinese population.

Authors:  Yanmei Ruan; Jinwei Zhang; Shiqi Mai; Wenfeng Zeng; Lili Huang; Chunrong Gu; Keping Liu; Yuying Ma; Zhi Wang
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

9.  Identification and Validation of Core Genes Involved in the Development of Papillary Thyroid Carcinoma via Bioinformatics Analysis.

Authors:  Xiaoyan Li; Jing He; Mingxia Zhou; Yun Cao; Yiting Jin; Qiang Zou
Journal:  Int J Genomics       Date:  2019-09-08       Impact factor: 2.326

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.